Oxfordbiotherapeutics
A T-Cell Biologist at Oxford Biotherapeutics contributes to the discovery and development of T-cell engagers for cancer treatment. The role involves designing and executing functional assays, analyzing complex datasets, and collaborating across teams to advance preclinical and early-stage development.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2004
Oxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
Oxfordbiotherapeutics didn’t post a salary, so this is our estimate from similar listings.